Adnexus Therapeutics' Acquisition

Adnexus Therapeutics was acquired by Bristol-Myers Squibb on September 24, 2007.

Adnexus Therapeutics, formerly Compound Therapeutics, is a private biotechnology company focused on development of medicines based on AdNectins(TM).…

Articles about Adnexus Therapeutics' Acquisition: